Trecator-SC Interactions
There are 150 drugs known to interact with Trecator-SC (ethionamide), along with 4 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 14 are major, and 136 are moderate.
- View all 150 medications that may interact with Trecator-SC
- View Trecator-SC alcohol/food interactions (1)
- View Trecator-SC disease interactions (4)
Most frequently checked interactions
View interaction reports for Trecator-SC (ethionamide) and the medicines listed below.
- Actemra (tocilizumab)
- Amicar (aminocaproic acid)
- Banzel (rufinamide)
- Baraclude (entecavir)
- Biaxin (clarithromycin)
- Blincyto (blinatumomab)
- Bosulif (bosutinib)
- CellCept (mycophenolate mofetil)
- Cosentyx (secukinumab)
- Cotellic (cobimetinib)
- Esbriet (pirfenidone)
- Idelvion (coagulation factor ix)
- Imbruvica (ibrutinib)
- Isentress (raltegravir)
- Jynarque (tolvaptan)
- Kalydeco (ivacaftor)
- Kynamro (mipomersen)
- midazolam
- Myambutol (ethambutol)
- Nydrazid (isoniazid)
- Ofev (nintedanib)
- Procysbi (cysteamine)
- Prolia (denosumab)
- Promacta (eltrombopag)
- Pulmozyme (dornase alfa)
- pyrazinamide
- Ravicti (glycerol phenylbutyrate)
- Stivarga (regorafenib)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir)
- Tyzeka (telbivudine)
Trecator-SC alcohol/food interactions
There is 1 alcohol/food interaction with Trecator-SC (ethionamide).
Trecator-SC disease interactions
There are 4 disease interactions with Trecator-SC (ethionamide) which include:
More about Trecator-SC (ethionamide)
- Trecator-SC consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: nicotinic acid derivatives
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.